367500-88-7

Basic information

• Product Name: tert-butyl 4-(4-hydroxypiperidin-1-yl)piperidine-1-carboxylate
• Synonyms: tert-butyl 4-(4-hydroxypiperidin-1-yl)piperidine-1-carboxylate;4-Hydroxy-1,4'-bipiperidinyl-1'-carboxylic acid tert-butyl ester;tert-Butyl 4-(4-hydroxypiperidin-1-yl)-1-piperidinecarboxylate;tert-Butyl 4-hydroxy-[1,4'-bipiperidine]-1'-carboxylate;1-Boc-4-(4-hydroxypiperidin-1-yl)piperidine;tert-Butyl4-hydroxy-1,4'-bipiperidine-1'-carboxylate98%;1-Boc-[1,4]bipiperidinyl-4-ol
• CAS NO: 367500-88-7
• Molecular Formula: C₁₅H₂₈N₂O₃
• Molecular Weight: 284.39442
• Mol File: 367500-88-7.mol

Chemical Properties

• Appearance: /
• Density: 1.124
• CAS DataBase Reference: tert-butyl 4-(4-hydroxypiperidin-1-yl)piperidine-1-carboxylate(CAS DataBase Reference)
• NIST Chemistry Reference: tert-butyl 4-(4-hydroxypiperidin-1-yl)piperidine-1-carboxylate(367500-88-7)
• EPA Substance Registry System: tert-butyl 4-(4-hydroxypiperidin-1-yl)piperidine-1-carboxylate(367500-88-7)

Safety Data

• Hazardous Substances Data: 367500-88-7(Hazardous Substances Data)

Usage

Uses

Used in Pharmaceutical Research and Drug Development:
Tert-butyl 4-(4-hydroxypiperidin-1-yl)piperidine-1-carboxylate is utilized as a building block for the synthesis of various bioactive molecules. Its unique structure and functional groups make it potentially useful for the development of drugs targeting specific receptors or biological pathways, contributing to the advancement of novel therapeutic agents.
Used in Medicinal Chemistry:
In the field of medicinal chemistry, tert-butyl 4-(4-hydroxypiperidin-1-yl)piperidine-1-carboxylate is employed for its steric hindrance and stability provided by the tert-butyl group. This feature makes the compound suitable for a wide range of synthetic applications, facilitating the creation of new and effective pharmaceutical compounds.

Upstream product

• 5382-16-1 4-HYDROXYPIPERIDINE 
• 79099-07-3 N-tert-butyloxycarbonylpiperidin-4-one 

Downstream Products

• 367500-72-9 4-(3,4-Dichloro-phenoxy)-[1,4']bipiperidinyl-1'-carboxylic acid tert-butyl ester 
• 550370-19-9 [1,4’-bipiperidin]-4-ol 
• 485391-82-0 C₂₄H₂₉Cl₂N₃O₄S 
• 485391-81-9 C₂₃H₂₇Cl₂N₃O₄S 
• 1413286-13-1 C₂₅H₂₆Cl₂N₄O₄ 
• 1413286-12-0 C₂₄H₂₆Cl₂N₂O₄ 
• 1413286-11-9 C₂₄H₂₆Cl₂N₂O₄ 
• 367497-18-5 C₂₅H₂₈Cl₂N₂O₅ 
• 367500-41-2 C₂₅H₃₀Cl₂N₂O₄S 
• 485391-83-1 C₁₇H₂₄Cl₂N₂O 
• 367500-74-1 4-(3,4-dichloro-phenoxy)-[1,4']bipiperidine 
• 1413286-17-5 C₂₉H₃₄Cl₂N₆O₄ 
• 1413286-16-4 C₂₆H₃₁Cl₂N₃O₄ 
• 1413286-15-3 C₂₇H₃₂Cl₂N₂O₆S 

Relevant articles and documents

3-PHENYLSULPHONYL-QUINOLINE DERIVATIVES AS AGENTS FOR TREATING PATHOGENIC BLOOD VESSELS DISORDERS

The disclosure provides compounds, and compositions, including pharmaceutical compositions, kits that include the compounds, and methods of using (or administering) and making the compounds. The disclosure further provides compounds or compositions thereof for use in a method of modulating PLXDC1 (TEM7) and/or PLXDC2 or killing pathogenic blood vessles. The disclosure further provides compounds or compositions thereof for use in a method of treating a disease, disorder, or condition that is mediated, at least in part, by PEDF receptors or by angiogenesis.

The discovery of CCR3/H1 dual antagonists with reduced hERG risk

A series of dual CCR3/H1 antagonists based on a bispiperidine scaffold were discovered. Introduction of an acidic group overcame hERG liability. Bioavailability was optimised by modulation of physico-chemical properties and physical form to del

TRPV4 ANTAGONISTS

The present invention relates to quinoline analogs, pharmaceutical compositions containing them and their use as TRPV4 antagonists.

Chemical compounds

The present invention provides a compound of a formula (I): wherein the variables are defined herein; to a process for preparing such a compound; and to the use of such a compound in the treatment of a chemokine (such as CCR3) or H1 mediated disease state.